Sign in to view content

Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2018

Related

A Comparison of the Anatomical Efficacy of Brolucizumab Versus Aflibercept in nAMD Patients: Matched 16-Week Results From the HAWK and HARRIER Studies
Pravin U. Dugel, MD
Annual Meeting Talks
2018
Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results
Sam E. Mansour, MD, MSc,FACS, FRCS(C)
Annual Meeting Talks
2018
Heads-Free!: 3D Head-Mounted Display System for Vitreoretinal Surgery
Murat Oncel, MD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more